Sara Barrington
Chief Executive Officer at VERICI DX PLC
Profile
Ms. Sara J.
Barrington is a Chief Executive Officer & Executive Director at Verici Dx Plc and a Chief Commercial Officer at Kantaro Biosciences LLC.
She is on the Board of Directors at LungLife AI, Inc. and Verici Dx Plc.
Ms. Barrington was previously employed as a CFO & EVP-Business Operations by Bruin Biometrics LLC, a Chief Financial Officer by Exosome Diagnostics, Inc., and a Chief Financial Officer by Ausam Biotechnologies, Inc. She also served on the board at Bruin Biometrics Europe Ltd.
She received her undergraduate degree from the University of Lancaster.
Sara Barrington active positions
Companies | Position | Start |
---|---|---|
VERICI DX PLC | Chief Executive Officer | 19/08/2020 |
LUNGLIFE AI, INC. | Director/Board Member | 08/07/2021 |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Corporate Officer/Principal | - |
Former positions of Sara Barrington
Companies | Position | End |
---|---|---|
LUNGLIFE AI, INC. | Chief Executive Officer | 01/05/2020 |
Bruin Biometrics LLC
Bruin Biometrics LLC Medical SpecialtiesHealth Technology Bruin Biometrics LLC manufactures biometric-sensor based medical devices. The company was founded by Martin Burns in 2009 and is headquartered in Los Angeles, CA. | Director of Finance/CFO | 01/11/2018 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Director of Finance/CFO | 01/01/2014 |
Ausam Biotechnologies, Inc.
Ausam Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Ausam Biotechnologies, Inc. provides biophysics and physiology research and development services. | Director of Finance/CFO | 01/01/2005 |
Bruin Biometrics Europe Ltd. | Director/Board Member | - |
Training of Sara Barrington
University of Lancaster | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
LUNGLIFE AI, INC. | Health Services |
VERICI DX PLC | Health Services |
Private companies | 5 |
---|---|
Ausam Biotechnologies, Inc.
Ausam Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Ausam Biotechnologies, Inc. provides biophysics and physiology research and development services. | Commercial Services |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Health Technology |
Bruin Biometrics Europe Ltd. | |
Bruin Biometrics LLC
Bruin Biometrics LLC Medical SpecialtiesHealth Technology Bruin Biometrics LLC manufactures biometric-sensor based medical devices. The company was founded by Martin Burns in 2009 and is headquartered in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- Sara Barrington